Literature DB >> 28515123

All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages.

Qian Zhou1, Miao Xian1, Senfeng Xiang1, Danyan Xiang1, Xuejing Shao1, Jincheng Wang1, Ji Cao1, Xiaochun Yang1, Bo Yang1, Meidan Ying2, Qiaojun He2.   

Abstract

M2-polarized tumor-associated macrophages (TAM) play a critical role in cancer invasion and metastasis. Here, we report that M2 macrophages enhanced metastasis of K7M2 WT osteosarcoma cells to the lungs in mice, thus establishing M2 TAMs as a therapeutic target for blocking osteosarcoma metastasis. We found that all-trans retinoic acid (ATRA) inhibited osteosarcoma metastasis via inhibiting the M2 polarization of TAMs. ATRA suppressed IL13- or IL4-induced M2-type macrophages, and then inhibited migration of osteosarcoma cells as promoted by M2-type macrophages in vitro ATRA reduced the number of pulmonary metastatic nodes of osteosarcoma and decreased expression of M2-type macrophages in metastatic nodes both in intravenous injection and orthotopic transplantation models. ATRA's effect was independent of conventional STAT3/6 or C/EBPβ signaling, which regulate M2-like polarization of macrophages. Quantitative genomic and functional analyses revealed that MMP12, a macrophage-secreted elastase, was elevated in IL13-skewed TAM polarization, whereas ATRA treatment downregulated IL13-induced secretion of MMP12. This downregulation correlates with the antimetastasis effect of ATRA. Our results show the role of TAM polarization in osteosarcoma metastasis, identify a therapeutic opportunity for antimetastasis treatment, and indicate ATRA treatment as an approach for preventing osteosarcoma metastasis via M2-type polarization intervention. Cancer Immunol Res; 5(7); 547-59. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28515123     DOI: 10.1158/2326-6066.CIR-16-0259

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  39 in total

1.  Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.

Authors:  Xue-Jing Shao; Sen-Feng Xiang; Ying-Qian Chen; Ning Zhang; Ji Cao; Hong Zhu; Bo Yang; Qian Zhou; Mei-Dan Ying; Qiao-Jun He
Journal:  Acta Pharmacol Sin       Date:  2019-07-11       Impact factor: 6.150

2.  Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.

Authors:  Yang Su; Yan Zhou; Yuan-Jue Sun; Ya-Ling Wang; Jun-Yi Yin; Yu-Jing Huang; Jian-Jun Zhang; Ai-Na He; Kun Han; Hui-Zhen Zhang; Yang Yao; Xiao-Bin Lv; Hai-Yan Hu
Journal:  J Mol Med (Berl)       Date:  2018-11-13       Impact factor: 4.599

3.  Tumor-associated macrophages in osteosarcoma.

Authors:  Yi Zhao; Benzheng Zhang; Qianqian Zhang; Xiaowei Ma; Helin Feng
Journal:  J Zhejiang Univ Sci B       Date:  2021-11-15       Impact factor: 3.066

4.  All-trans-retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating autophagy.

Authors:  Shuyu Fang; Chaoqun Hu; Lei Xu; Jiejie Cui; Li Tao; Mengjia Gong; Yi Wang; Yun He; Tongchuan He; Yang Bi
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 5.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

Review 6.  Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics.

Authors:  Li Jiang; Rong Dong; Meidan Ying; Qiaojun He; Ji Cao; Bo Yang
Journal:  Br J Pharmacol       Date:  2018-11-08       Impact factor: 8.739

Review 7.  MDSC: Markers, development, states, and unaddressed complexity.

Authors:  Samarth Hegde; Andrew M Leader; Miriam Merad
Journal:  Immunity       Date:  2021-05-11       Impact factor: 31.745

Review 8.  Turning 'Cold' tumors 'Hot': immunotherapies in sarcoma.

Authors:  Jeff Rytlewski; Mohammed M Milhem; Varun Monga
Journal:  Ann Transl Med       Date:  2021-06

9.  Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis.

Authors:  Huapeng Guan; Hao Xu; Jinshui Chen; Weishan Wu; Dongfeng Chen; Yungang Chen; Jianzhong Sun
Journal:  Cancer Cell Int       Date:  2021-07-02       Impact factor: 5.722

Review 10.  The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.

Authors:  Huogang Wang; Mingo M H Yung; Hextan Y S Ngan; Karen K L Chan; David W Chan
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.